Figure 2
Structural models of [2Fe–2S] BOLA1–GRX5 (A) and of [2Fe–2S] BOLA3–GRX5 (B) obtained by molecular docking from NMR mapping [21]. SmYrbA was superimposed on BolA homologs in BOLA1–GRX5 (C) and in BOLA3–GRX5 (D). GRX5, BOLA1, BOLA3 and SmYrbA structures are in red, green, blue and purple, respectively. The invariant C-terminal histidine residue (His67, His96 or His102 in SmYrbA, BOLA3 or BOLA1, respectively), conserved residues present in the [H/C]-loop (His32, Cys59 or His67 in SmYrbA, BOLA3 or BOLA1, respectively), the catalytic cysteine Cys67 in GRX5 and GSH involved in Fe–S cluster binding are shown.
Superposition of SmYrbA on to the structural models of human BOLA1–GRX5 and BOLA3–GRX5 holo-heterodimers

Structural models of [2Fe–2S] BOLA1–GRX5 (A) and of [2Fe–2S] BOLA3–GRX5 (B) obtained by molecular docking from NMR mapping [21]. SmYrbA was superimposed on BolA homologs in BOLA1–GRX5 (C) and in BOLA3–GRX5 (D). GRX5, BOLA1, BOLA3 and SmYrbA structures are in red, green, blue and purple, respectively. The invariant C-terminal histidine residue (His67, His96 or His102 in SmYrbA, BOLA3 or BOLA1, respectively), conserved residues present in the [H/C]-loop (His32, Cys59 or His67 in SmYrbA, BOLA3 or BOLA1, respectively), the catalytic cysteine Cys67 in GRX5 and GSH involved in Fe–S cluster binding are shown.

Close Modal

or Create an Account

Close Modal
Close Modal